-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
According to NMPA's official website, recently, NMPA approved the listing of Hesco's declared Class 1 innovative drug cyclophenol injection (commodity name: Sisshuning) through the priority review approval process.
drug is an innovative drug with independent research and intellectual property rights in China, which is used for sedative sedative examination in the digestive tract endoscopy.
source: MED2.0 China Drug Review Database Cyclophenol is GABAA-subjector astigtor, an anaesthetic sedative.
only two of the five previously approved new narcotic drugs were Class 1 new drugs (Hengrui announced on January 3, 2020 that toluazoleon for injection toluene was approved for listing).
approved this time, making it the third new Class 1 drug to go on sale this year.
In China's urban public hospitals, county-level public hospitals, urban community centers and township hospitals (China's public medical institutions) terminal nervous system drug market, the sales volume of narcotic drugs has exceeded 16 billion yuan, the growth rate in 2018-2019 remained above 10%, the first half of 2020 affected by the epidemic patients reduced the frequency of surgery, the growth rate fell by 15%.
source: NMPA official website, MiNet database